SEGAL, Lloyd M.

Track

Insider profile

Performance

Overall performance
2.2
Performance over holding periods
2.2
30 days 90 days 120 days
Average return -3% 8.2% 15.1%
Success rate 2% 68% 82%
Transactions
4 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
SEGAL, Lloyd M.'s trades of Repare Therapeutics Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2025-03-14 2025-03-13
S Sale
83,648 +0.7%
459.02
US$118,899 		83,648 +0.7% 459.02 US$118,899
2025-03-07 2025-02-15
PP Planned purchase
78,628 -28.4%
316.03
US$4,987,963 		78,628 -28.4% 316.03 US$4,987,963
2025-03-07 2024-08-15
PP Planned purchase
46,293 -9.9%
369.34
US$3,484,817 		46,293 -9.9% 369.34 US$3,484,817
2024-03-28 2024-03-28
PlS Planned sale
2,650 -10.1%
4.62
US$12,243 		2,650 -10.1% 4.62 US$12,243
2024-03-28 2024-03-27
PlS Planned sale
2,650 -9.1%
4.63
US$12,270 		2,650 -9.1% 4.63 US$12,270
2024-03-28 2024-03-26
PlS Planned sale
2,650 -8.4%
4.64
US$12,296 		2,650 -8.4% 4.64 US$12,296
2024-03-28 2024-03-25
PlS Planned sale
2,650 -7.7%
4.79
US$12,694 		2,650 -7.7% 4.79 US$12,694
2024-03-04 2024-02-15
PP Planned purchase
2,000 +32.6%
5.91
US$11,820 		2,000 +32.6% 5.91 US$11,820
2025-03-07 2023-08-15
PP Planned purchase
967 +13.2%
8.26
US$7,987 		967 +13.2% 8.26 US$7,987
2025-03-07 2023-02-15
PP Planned purchase
1,217 +19.9%
9.80
US$11,927 		1,217 +19.9% 9.80 US$11,927
2022-02-28 2022-02-15
PP Planned purchase
729
12.71
US$9,266 		729 12.71 US$9,266
2021-06-04 2021-06-04
S Sale
29,352 -23.1%
30.94
US$908,054 		29,352 -23.1% 30.94 US$908,054
2021-06-04 2021-06-04
S Sale
5,000 -50.0%
31.25
US$156,254 		5,000 -50.0% 31.25 US$156,254
2021-06-04 2021-06-03
S Sale
6,648 -5.0%
31.74
US$211,034 		6,648 -5.0% 31.74 US$211,034